Ana
Martín García
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (7)
2022
-
Cervical dissecting extravasation of oxaliplatin: A case report
Molecular and Clinical Oncology, Vol. 16, Núm. 3
-
Erratum to “Takotsubo syndrome and cancer, clinical and prognostic implications, insights of RETAKO” [Med Clin (Barc). 2020;155(12):521-528] (Medicina Clinica (2020) 155(12) (521–528), (S0025775320301895), (10.1016/j.medcli.2020.01.033))
Medicina Clinica
2021
-
Stratification and management of cardiovascular risk in cancer patients. A consensus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC, and AECC
Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 438-448
2020
-
Takotsubo syndrome and cancer, clinical and prognostic implications, insights of RETAKO
Medicina Clinica, Vol. 155, Núm. 12, pp. 521-528
2019
-
Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations
Revista Espanola de Cardiologia, Vol. 72, Núm. 9, pp. 749-759
2018
-
Short- and Long-Term Prognostic Relevance of Cardiogenic Shock in Takotsubo Syndrome: Results From the RETAKO Registry
JACC: Heart Failure, Vol. 6, Núm. 11, pp. 928-936
-
Tako-tsubo Syndrome in Men: Rare, but With Poor Prognosis
Revista Espanola de Cardiologia, Vol. 71, Núm. 9, pp. 703-708